WEX News & Events

Impactive Capital, which together with its affiliates is one of the largest shareholders of Wex with an ownership interest of approximately 4.9%, announced that it has filed definitive proxy materials in connection with the company's annual meeting of stockholders, currently scheduled for May 5, and sent a letter to shareholders in which the firm says it details "how the WEX Board of Directors has failed to respond to clear investor discontent, neglected to exercise adequate oversight of management, and taken desperate steps to entrench itself." In its letter, Impactive also says it "highlights that Board change is needed to course correct and stem the years-long tide of underperformance by the Company, which has led to a severe undervaluation by the market. As Impactive points out, there is no reason why Wex, with the right strategy and operational execution, could not close the valuation gap to its closest competitor, Corpay."

WEX announced the launch of a Health Reimbursement Arrangement designed to help employers manage the surging demand and escalating costs of GLP-1 medications . WEX's specialized solution enables organizations to carve out GLP-1 coverage into a defined-contribution HRA. This puts the power back to the employer amidst shifting economic conditions by helping protect the organization's core medical plan from unpredictable utilization and premium inflation. By customizing everything from funding to reimbursement rules, employers gain clarity and control over pricing, while ensuring their employees have a reliable safety net for their health journeys.

Impactive Capital together with its affiliates, one of the largest shareholders of WEX with an ownership interest of approximately 5.0%, announced that it has nominated four candidates - Kurt Adams, Ellen Alemany, Ken Cornick and Lauren Taylor Wolfe - for election to the WEX Board of Directors at the upcoming 2026 annual meeting of stockholders.